Table 2.4 Other Cardiovascular Conditions in Patients Without Symptoms of Ischemia
Clinical Scenario Text | ECG Treadmill | Stress Nuclear MPI | Stress Echo | Stress CMR | CAC | CCTA | Cath | No Test | |
|---|---|---|---|---|---|---|---|---|---|
Newly-Diagnosed Heart Failure (Resting LV Function Previously Assessed but No Prior CAD Evaluation) | |||||||||
51. | Newly diagnosed HFpEF | M (4) | A (7) | A (8) | A (7) | R (3) | A (7) | M (6) | R (3) |
52. | Newly diagnosed HFrEF | M (4) | A (7) | A (8) | A (8) | R (2) | A (7) | A (8) | R (1) |
53. | Screening for transplant vasculopathy | R (3) | A (7) | A (7) | A (7) | R (1) | A (7) | A (8) | Â |
Evaluation of Arrhythmias Without Ischemic Equivalent (No Prior Cardiac Evaluation) | |||||||||
54. | Infrequent PVCs | M (4) | R (2) | R (2) | R (2) | R (2) | R (1) | R (1) | A (8) |
55. | Frequent PVCs or nonsustained VT | A (7) | A (7) | A (7) | A (7) | R (3) | M (6) | M (5) | M (4) |
56. | Paroxysmal supraventricular tachycardia | M (5) | R (2) | R (3) | R (3) | R (1) | R (2) | R (1) | M (5) |
57. | New-onset atrial fibrillation/flutter | M (5) | R (3) | R (3) | R (3) | R (2) | R (3) | R (1) | M (5) |
58. | Prior to initiation of antiarrhythmic therapy in patients with high global CAD risk | M (6) | A (7) | A (7) | A (7) | R (3) | A (7) | R (3) | R (3) |
59. | Exercise-induced VT | A (7) | A (7) | A (8) | A (7) | R (2) | A (7) | A (7) | R (1) |
60. | Sustained VT | A (7) | A (7) | A (7) | A (7) | R (2) | A (7) | A (7) | R (1) |
61. | Ventricular fibrillation | M (4) | A (7) | A (7) | A (7) | R (1) | A (7) | A (8) | R (1) |
Syncope Without Ischemic Equivalent | |||||||||
62. | Initial evaluation suggests CV abnormalities | A (7) | A (7) | A (7) | A (7) | R (3) | M (6) | M (5) | R (3) |
63. | Initial evaluation suggests other etiology | M (4) | R (3) | M (4) | R (3) | R (2) | R (2) | R (1) | M (6) |
Cardio-oncology | |||||||||
64. | Prior chest radiation, no symptoms, > 5 y ago | M (4) | M (4) | M (6) | M (5) | M (6) | M (6) | R (2) | M (5) |